Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Clinical Trials

group photo


(Last updated 05/04/2021)

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks (SHORTER). (NCT04422132) Click here to enquire about this study.

  • IRB# 20-03021572 Click here to sign up for this study.

NYP- WELCOME trial (Weill Cornell Medicine Employees)

  •  IRB# 20-04021831. Click here to sign up for this study.

Prone partial breast irradiation (PBI): Prospective randomized controlled non-inferiority trial to compare radiation fibrosis with five versus three fractions (NCT02755896) Click here to enquire about this study.

  • IRB # 1505016201

Accelerated Radiation Therapy (ART) To the Breast and Nodal Stations after Neo-Adjuvant Chemotherapy and Surgery: A Feasibility Study (NCT02917421)Click here to enquire about this study.

  • IRB # 1602017017    

Radiation and immune checkpoints blockade in metastatic NSCLC (BMS # CA209-632) (NCT03168464)Click here to enquire about this study. 

  • IRB # 1607017434

Effect of radiotherapy variables on circulating effectors of immune response and local microbiome (NCT03383107)Click here to enquire about this study.

  • IRB # 1708018471 

Pembrolizumab and Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients (NCT03449238)Click here to enquire about this study. 

  • IRB # 1710018694

PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) (NCT03663218)Click here to enquire about this study. 

  • IRB # 1712018849

 Prospective Randomized study of Accelerated Radiation Therapy (PRART) (NCT04175210). Click here to enquire about this study.

  • IRB # 19-07020533

Converting HR+ Breast Cancer Into an Individualized Vaccine (NCT03804944). Click here to enquire about this study.

  • IRB # 1808019498

Personalized Second Chance Breast Conservation (PSCBC): A Two Center Prospective Phase II Clinical Study. NCT04371913. Click here to enquire about this study. Click here to enquire about this study.

  • IRB # 19-07020531

Single-Arm Phase II Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer (PSMA SBRT-SIB)  NCT04402151. Click here to enquire about this study.

  • IRB # 19-10020928

CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer  NCT04220476. Click here to enquire about this study.

  • IRB # 19-09020752

PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer NCT04220983. Click here to enquire about this study.

  • IRB# 19-04020263

The Irradiated Breast Tumor Cavity: A Biological Hub. Click here to enquire about this study.

  • IRB # 19-07020524

Prospective phase II Study of Stereotactic MR-guided on-table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Inoperable Locally Advanced Pancreatic Cancer. 
NCT03621644. Click here to enquire about this study.

  • IRB # 19-04020160


Not accepting any new patients. 

last updated 04/02/2021


RTOG0534: A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only RT (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy (NCT00567580)  

  • IRB # 0810010069 

An Open-Label Multicenter Phase 1b Study of E7046 in Combination with Radiotherapy/ Chemo radiotherapy (RT/CRT) in preoperative treatment of Subjects with Rectum Cancer (NCT03152370)

  • IRB # 1612017834

NRG GU003 - A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT) (NCT03274687)

  • IRB # 1708018460

MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer (SIBRT) (NCT03664193)

  • IRB # 1802019010

A Phase II randomized controlled trial of PD-1/PDL-1 axis blockade versus PD-1/PDL-1 axis blockade plus radiotherapy in metastatic genitourinary (renal/urothelial) malignancies (NCT03115801)

  • IRB # 1606017369   


Closed studies. 

last updated 04/02/2021

ISABR STUDY: A Multi-Site Randomized Phase I/II Study of Stereotactic Ablative Body Radiotherapy +/- MEDI 4736 (Durvalumab) for Medically Inoperable Early- Stage Non-Small Cell Lung Cancer

  • IRB # 19-04020249

Randomized trial of image-guided stereotactic radiation therapy  (IG-SRT) in prostate cancer (NCT02911922)

  • IRB # 1604017139 

A First-in-Human Study of Repeat Dosing with REGN2810, a Monoclonal, Fully Human Antibody to Programmed Death - 1 (PD-1), as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies (NCT02383212)

  • IRB # 1505016229

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer (NCT02538471)

  • IRB # 1505016222

Phase I/II study of TLR7 agonist Imiquimod, Cyclophosphamide, and Radiotherapy in Breast Cancer Patients with Chest Wall Recurrence or Skin Metastases (NCT01421017)

  • IRB # 1505016228


 group photo

Clinical Trials Contact Information

Stich Radiation Oncology Clinical Trials

Maria Fenton-Kerimian,N.P.
Tel: (212) 746-6074

Sharanya Chandrasekhar
Tel: (646) 962-2196

Pragya Yadav
Tel: (646) 962-2199

Contact Us

David H. Koch Center

New York-Presbyterian Hospital/
Weill Cornell Medical Center
1283 York Avenue, 4th floor
New York, NY 10065
Tel: (212) 746-3600
View Map

Stich Radiation Oncology Center

New York-Presbyterian Hospital/
Weill Cornell Medical Center
525 East 68th Street
New York, NY 10065
Tel: (212) 746-3600
View Map

The Arnold Center For Radiation Oncology

New York-Presbyterian Hospital Queens
56-45 Main Street
(56th Avenue between Main Street and 141st Street)
Flushing, NY 11355
Tel: (718) 670-1501

View Map